| Identification | Back Directory | [Name]
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | [CAS]
1260614-73-0 | [Synonyms]
Tofatinib Impurity 18
Tofacitinib IMpurity N
Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4S))
N-Methyl-N-[(3S,4S)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3S,4S)-4-Methyl-3-piperidinyl]- | [Molecular Formula]
C13H19N5 | [MDL Number]
MFCD09878609 | [MOL File]
1260614-73-0.mol | [Molecular Weight]
245.32 |
| Chemical Properties | Back Directory | [Melting point ]
156-160°C | [density ]
1?+-.0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
Methanol (Slightly), Water (Slightly) | [form ]
Solid | [pka]
13.36±0.50(Predicted) | [color ]
Off-White |
| Hazard Information | Back Directory | [Uses]
Tofacitinib impurity N is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. |
|
|